Sumimasa Nagai

5PUBLICATIONS
10CO-AUTHORS
Molecular targetsMedicinal and biomolecular chemistry not elsewhere classifiedCancer geneticsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 14, 2025
Regulatory Approval of CAR-T Cell and BsAb Products for Lymphoid Neoplasms in the US, EU, and Japan.

Kensuke Matsuda, Atsushi Nonami, Kayo Shinohara

|Sep 10, 2024
Characteristics of Drugs from Non-Global Companies for Hematologic Malignancies and Impact on Global Regulatory Approval.

Kensuke Matsuda, Sumimasa Nagai, Koichi Sugimoto

|Jul 30, 2022
Recommendations related to the analytical equivalence assessment of gene panel testing.

Sumimasa Nagai, Hiroshi Nishihara, Takayoshi Suzuki

|Aug 07, 2019
Flexible and Expedited Regulatory Review Processes for Innovative Medicines and Regenerative Medical Products in the US, the EU, and Japan.

Sumimasa Nagai

|Feb 18, 2018
Drug approval based on randomized phase 3 trials for relapsed malignancy: analysis of oncologic drugs granted accelerated approval, publications and clinical trial databases.

Sumimasa Nagai, Keiya Ozawa

Pageof 1

Frequent Collaborators

2 joint publications

Kensuke Matsuda

1 joint publications

Takayoshi Suzuki

1 joint publications

Kazuto Nishio

1 joint publications

Hiroya Taniguchi